trial · primary record
allogeneic mesenchymal stem cells
Urinary Incontinence Stress
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2027-03 |
| Primary endpoint | Proportion of patients with at least one of the complictations derived from the treatment. |
| Registry ID | NCT06738576 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:45.313Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06738576
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.